Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Sep. 20, 2021

MC-100093 attenuates cocaine relapse in rats

Sep. 16, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

New target identified for acetaminophen liver injury

June 14, 2021

NIDA studies TRV-734 in phase II for opioid use disorder

May 31, 2021

FDA clears IND for Lyndra's LYN-014 for weekly treatment of opioid use disorder

May 7, 2021

FDA approves Kloxxado for opioid overdose

May 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...